Cargando…
Identification of a Prognostic Microenvironment-Related Gene Signature in Glioblastoma Patients Treated with Carmustine Wafers
SIMPLE SUMMARY: Carmustine wafer (CW) implantation into the resection cavity of patients operated for glioblastoma (GBM) was approved as an adjuvant treatment before the Stupp Protocol. Although contrasting clinical results limited its use, our retrospective study on 116 GBM treated with CW showed a...
Autores principales: | Manini, Ivana, Dalla, Emiliano, Vendramin, Vera, Cesselli, Daniela, Di Loreto, Carla, Skrap, Miran, Ius, Tamara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320240/ https://www.ncbi.nlm.nih.gov/pubmed/35884475 http://dx.doi.org/10.3390/cancers14143413 |
Ejemplares similares
-
Carmustine Wafers Implantation in Patients With Newly Diagnosed High Grade Glioma: Is It Still an Option?
por: Ricciardi, Luca, et al.
Publicado: (2022) -
The miRNA Content of Exosomes Released from the Glioma Microenvironment Can Affect Malignant Progression
por: Caponnetto, Federica, et al.
Publicado: (2020) -
Heterogeneity Matters: Different Regions of Glioblastoma Are Characterized by Distinctive Tumor-Supporting Pathways
por: Manini, Ivana, et al.
Publicado: (2020) -
Semaphorin-7A on Exosomes: A Promigratory Signal in the Glioma Microenvironment
por: Manini, Ivana, et al.
Publicado: (2019) -
Cerebral Infarction Related to Carmustine Wafers in Glioblastoma: A Case Report
por: Nakada, Mitsutoshi, et al.
Publicado: (2014)